These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 21636247)

  • 1. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
    Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
    J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity.
    Abreu JR; Martina S; Verrijn Stuart AA; Fillié YE; Franken KL; Drijfhout JW; Roep BO
    Clin Exp Immunol; 2012 Oct; 170(1):57-65. PubMed ID: 22943201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
    Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
    Mallone R; Scotto M; Janicki CN; James EA; Fitzgerald-Miller L; Wagner R; Gottlieb P; Thorpe J; Jospe N; Durinovic-Bellò I; Boitard C; Lou O; Dayan CM; Wong FS;
    Diabetes Metab Res Rev; 2011 Nov; 27(8):720-6. PubMed ID: 22069251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.
    Velthuis JH; Unger WW; Abreu JR; Duinkerken G; Franken K; Peakman M; Bakker AH; Reker-Hadrup S; Keymeulen B; Drijfhout JW; Schumacher TN; Roep BO
    Diabetes; 2010 Jul; 59(7):1721-30. PubMed ID: 20357361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
    Ouyang Q; Standifer NE; Qin H; Gottlieb P; Verchere CB; Nepom GT; Tan R; Panagiotopoulos C
    Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
    Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
    Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.
    Mallone R; Martinuzzi E; Blancou P; Novelli G; Afonso G; Dolz M; Bruno G; Chaillous L; Chatenoud L; Bach JM; van Endert P
    Diabetes; 2007 Mar; 56(3):613-21. PubMed ID: 17327428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I epitope discovery in type 1 diabetes.
    van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
    Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells.
    Kronenberg D; Knight RR; Estorninho M; Ellis RJ; Kester MG; de Ru A; Eichmann M; Huang GC; Powrie J; Dayan CM; Skowera A; van Veelen PA; Peakman M
    Diabetes; 2012 Jul; 61(7):1752-9. PubMed ID: 22522618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.
    Skowera A; Ellis RJ; Varela-Calviño R; Arif S; Huang GC; Van-Krinks C; Zaremba A; Rackham C; Allen JS; Tree TI; Zhao M; Dayan CM; Sewell AK; Unger WW; Drijfhout JW; Ossendorp F; Roep BO; Peakman M
    J Clin Invest; 2008 Oct; 118(10):3390-402. PubMed ID: 18802479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope.
    Yang J; Danke N; Roti M; Huston L; Greenbaum C; Pihoker C; James E; Kwok WW
    J Autoimmun; 2008 Aug; 31(1):30-41. PubMed ID: 18385016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing in the endoplasmic reticulum generates an epitope on the insulin A chain that stimulates diabetogenic CD8 T cell responses.
    Brosi H; Reiser M; Rajasalu T; Spyrantis A; Oswald F; Boehm BO; Schirmbeck R
    J Immunol; 2009 Dec; 183(11):7187-95. PubMed ID: 19890053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
    Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
    BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
    Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P
    J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive mapping of HLA-A0201-restricted CD8 T-cell epitopes on PDC-E2 in primary biliary cirrhosis.
    Matsumura S; Kita H; He XS; Ansari AA; Lian ZX; Van De Water J; Yamamoto K; Tsuji T; Coppel RL; Kaplan M; Gershwin ME
    Hepatology; 2002 Nov; 36(5):1125-34. PubMed ID: 12395322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
    Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
    Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
    Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
    J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.